Skip to main content
. 2023 May 10;34(6):941–960. doi: 10.1021/acs.bioconjchem.3c00174

Figure 1.

Figure 1

Yearly growth of the number of documents (patents and nonpatents) in the CAS Content Collection related to the PEG–lipids immunologically induced adverse effects such as anti-PEG antibodies generation, ABC, and CARPA.